Calendar

pharmadog

Week of Mar 14, 2022

Mar 16, 2022approval1609d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL

full page →Restasis →fda approvals ↗

Mar 16, 2022approval1609d agoMETHADONE HYDROCHLORIDE — FDA approvalMETHADONE HYDROCHLORIDE

Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL

full page →METHADONE HYDROCHLORIDE →fda approvals ↗

Mar 16, 2022approval1609d agoMETHADONE HYDROCHLORIDE — FDA approvalMETHADONE HYDROCHLORIDE

Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL

full page →METHADONE HYDROCHLORIDE →fda approvals ↗

Mar 16, 2022approval1609d agoMETHADONE HYDROCHLORIDE — FDA approvalMETHADONE HYDROCHLORIDE

Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL

full page →METHADONE HYDROCHLORIDE →fda approvals ↗

Mar 16, 2022approval1609d agoMETHADONE HYDROCHLORIDE — FDA approvalMETHADONE HYDROCHLORIDE

Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL

full page →METHADONE HYDROCHLORIDE →fda approvals ↗

Mar 16, 2022approval1609d agoRINVOQ (UPADACITINIB) — FDA approvalupadacitinib tartrate ER

Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →upadacitinib tartrate ER →fda approvals ↗

Mar 17, 2022approval1608d agoLACOSAMIDE — FDA approvalLACOSAMIDE

Sponsor: HETERO LABS LTD V. Form: TABLET. Route: ORAL

full page →LACOSAMIDE →fda approvals ↗

Mar 18, 2022approval1607d agoCEFEPIME AND DEXTROSE IN DUPLEX CONTAINER (CEFEPIME HYDROCHLORIDE) — FDA approvalSamson Medical Technologies LLC

Sponsor: B BRAUN. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 18, 2022approval1607d agoCYLTEZO (ADALIMUMAB-ADBM) — FDA approvalCYLTEZO

Sponsor: BOEHRINGER INGELHEIM. Form: INJECTABLE. Route: INJECTION

full page →CYLTEZO →fda approvals ↗

Mar 18, 2022approval1607d agoZTALMY (GANAXOLONE) — FDA approvalganaxolone

Sponsor: IMMEDICA PHARMA. Form: SUSPENSION. Route: ORAL

full page →ganaxolone →fda approvals ↗

Week of Mar 21, 2022

Mar 21, 2022approval1604d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

full page →pembrolizumab →fda approvals ↗

Mar 21, 2022approval

Week of Mar 28, 2022

Mar 28, 2022approval1597d agoCAPRELSA (VANDETANIB) — FDA approvalvandetanib

Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL

full page →vandetanib →fda approvals ↗

Mar 28, 2022approval

Week of Apr 4, 2022

Apr 5, 2022approval1589d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: HIKMA. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Apr 5, 2022approval

Week of Apr 11, 2022

Apr 11, 2022approval1583d agoNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalrimegepant sulfate ODT

Sponsor: PFIZER. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →rimegepant sulfate ODT →fda approvals ↗

Apr 12, 2022approval

Week of Apr 18, 2022

Apr 20, 2022approval1574d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

Sponsor: GENUS. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗

Apr 21, 2022approval

← prev

page 68 of 582

Week of Mar 14, 2022

Week of Mar 21, 2022

Week of Mar 28, 2022

Week of Apr 4, 2022

Week of Apr 11, 2022

Week of Apr 18, 2022